首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
【24h】

Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria

机译:IgA肾病伴蛋白尿最少或无的长期结果

获取原文
           

摘要

The long-term outcome of patients with IgA nephropathy who present with normal renal function, microscopic hematuria, and minimal or no proteinuria is not well described. Here, we studied 141 Caucasian patients with biopsy-proven IgA nephropathy who had minor abnormalities at presentation and a median follow-up of 108 months. None of the patients received corticosteroids or immunosuppressants. We reviewed renal biopsies using the Oxford classification criteria. In this sample, 46 (32%) patients had mesangial proliferation, whereas endocapillary proliferation, focal glomerulosclerosis, and tubulointerstitial abnormalities were uncommon. Serum creatinine increases 50% and 100% were observed in five (3.5%) patients and one (0.7%) patient, respectively; no patients developed ESRD. After 10, 15, and 20 years, 96.7%, 91.9%, and 91.9% of patients maintained serum creatinine values less than a 50% increase, respectively. Using Cox proportional hazards regression, the presence of segmental glomerulosclerosis was the only factor that significantly associated with a 50% increase in serum creatinine. Clinical remission occurred in 53 (37.5%) patients after a median of 48 months. Proteinuria0.5 and 1.0 g/24 h developed in 21 (14.9%) and 6 (4.2%) patients, respectively. Median proteinuria at the end of follow-up was 0.1 g/24 h, with 41 (29.1%) patients having no proteinuria. At presentation, 23 (16.3%) patients were hypertensive compared with 30 (21.3%) patients at the end of follow-up; 59 (41.8%) patients were treated with renin-angiotensin blockers because of hypertension or increasing proteinuria. In summary, the long-term prognosis for Caucasian patients with IgA nephropathy who present with minor urinary abnormalities and normal renal function is excellent.
机译:肾功能正常,镜下血尿,蛋白尿少或无蛋白尿的IgA肾病患者的长期预后未得到很好的描述。在这里,我们研究了141例经活检证实为IgA肾病的白人患者,他们在就诊时有轻微异常,中位随访时间为108个月。没有患者接受皮质类固醇或免疫抑制剂。我们使用牛津分类标准对肾脏活检进行了回顾。在该样本中,有46名(32%)患者肾小球系膜增生,而毛细血管内增生,局灶性肾小球硬化和肾小管间质异常并不常见。分别在五名(3.5%)和一名(0.7%)患者中观察到血清肌酐增加> 50%和> 100%。没有患者发生ESR​​D。在10、15和20年后,分别有96.7%,91.9%和91.9%的患者血清肌酐值保持不足50%的增长。使用Cox比例风险回归,存在节段性肾小球硬化是唯一与血清肌酐升高> 50%显着相关的因素。中位48个月后,有53例(37.5%)患者出现了临床缓解。 21名患者(14.9%)和6名患者(4.2%)分别出现蛋白尿> 0.5和> 1.0 g / 24 h。随访结束时蛋白尿中位数为0.1 g / 24 h,其中41名(29.1%)患者无蛋白尿。介绍时,有23名(16.3%)高血压患者,而随访结束时为30名(21.3%); 59名(41.8%)患者因高血压或蛋白尿增加而接受了肾素-血管紧张素阻滞剂治疗。综上所述,白人患者IgA肾病的泌尿异常和肾功能正常的长期预后极好。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号